- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05627765
An Integrated Smoking Cessation and Alcohol Intervention for Young People
November 24, 2022 updated by: The Hong Kong Polytechnic University
An Integrated Smoking Cessation and Alcohol Intervention Among Hong Kong Chinese Young People: A Feasibility Randomized Controlled Trial
The study will be a three-arm randomized controlled trial in a convenience sample of 150 smokers aged 18-25 years with a drinking habit who will be recruited from smoking hotspots in Mong Kok.
Participants will be randomized into a standard treatment (ST), II, or control arm.
Participants in the ST arm will receive a brief smoking cessation intervention based on the Asking about tobacco use, Advising smokers to quit, Assessing their willingness to quit, Assisting in quitting, and Arranging for follow-up and Relevance, Risks, Rewards, Roadblocks and Repetition models.
Participants in the II arm will receive brief advice on alcohol use based on the FRAMES model in addition to the brief smoking cessation intervention.
Booster interventions will be provided to both ST and II arms at 1-week, 1-month, 3-month, and 6-month follow-up.
Participants in the control arm will receive leaflets on smoking cessation and alcohol abstinence.
Data collection will be done at baseline and at 1-week, 1-month, 3-month, and 6-month follow-ups.
Self-reported quitters at 6-month follow-up will be invited for biochemical validation.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ka Yan HO
- Phone Number: 27666417
- Email: kyeva.ho@polyu.edu.hk
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 23 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- smoked at least one cigarette in the past 30 days
- have consumed at least one cup of alcohol (10 ounces of beer, 4 ounces of wine, or 1 ounce of liquor) in the past 30 days
- speak Cantonese.
Exclusion Criteria:
- have a compromised mental status and/or communication problems
- participating in other smoking cessation interventions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standard treatment (ST) arm
Participants will receive a brief smoking cessation intervention based on the asking about tobacco use, Advising smokers to quit, Assessing their willingness to quit,Assisting in quitting, and Arranging for follow-up and relevance, risks, rewards, roadblocks and repetition models at baseline.
Booster interventions will be provided to ST arm at 1-week, 1-month, 3-month, and 6-month follow-up.
|
Participants will receive a brief smoking cessation intervention based on the asking about tobacco use, Advising smokers to quit, Assessing their willingness to quit,Assisting in quitting, and Arranging for follow-up and relevance, risks, rewards, roadblocks and repetition models at baseline.
Booster interventions will be provided to ST arm at 1-week, 1-month, 3-month, and 6-month follow-up.
|
Experimental: Integrated Intervention (II) arm
Participants in the II arm will receive brief advice on alcohol use based on the FRAMES model in addition to the brief smoking cessation intervention at baseline.
Booster interventions will be provided to ST arm at 1-week, 1-month, 3-month, and 6-month follow-up.
|
Participants will receive brief advice on alcohol use based on the FRAMES model, which is a well-established and effective brief intervention for drinking.
|
No Intervention: Control arm
Participants will be provided with two leaflets designed by Department of health: one for smoking cessation and another for alcohol abstinence.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
screening rate
Time Frame: 24 months
|
the number of people screened divided by the number of people available for screening
|
24 months
|
eligibility rate
Time Frame: 24 months
|
the number of eligible smokers divided by the number of screened people.
|
24 months
|
consent rate
Time Frame: 24 months
|
the number of eligible smokers who agree to participate divided by the number of eligible smokers
|
24 months
|
randomization rate
Time Frame: 24 months
|
the number of participants who are randomized divided by the number of eligible smokers who consent to participate
|
24 months
|
attendance rate
Time Frame: 24 months
|
the number of participants who complete the intervention divided by the number of participants who are randomized into the treatment arms
|
24 months
|
adherence to intervention
Time Frame: 24 months
|
the number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms
|
24 months
|
retention rate
Time Frame: 24 months
|
the number of participants who remain in the study
|
24 months
|
completion rate
Time Frame: 24 months
|
the number of participants who complete the questionnaire
|
24 months
|
missing data
Time Frame: 24 months
|
the percentage of missing data
|
24 months
|
adverse events
Time Frame: 24 months
|
unfavorable or unintended events
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
self-reported quit rate
Time Frame: 6 month
|
self-report no use of any tobacco products
|
6 month
|
biochemically validated quit rate
Time Frame: 6 month
|
biochemically verified
|
6 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Ka Yan HO, The Hong Kong Polytechnic University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
April 1, 2023
Primary Completion (Anticipated)
July 31, 2024
Study Completion (Anticipated)
July 31, 2024
Study Registration Dates
First Submitted
April 13, 2022
First Submitted That Met QC Criteria
November 24, 2022
First Posted (Actual)
November 28, 2022
Study Record Updates
Last Update Posted (Actual)
November 28, 2022
Last Update Submitted That Met QC Criteria
November 24, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19200161
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcohol Drinking
-
University of North Carolina, Chapel HillNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingDrinking Behavior | Adolescent Behavior | Drinking, Alcohol | Alcohol Drinking, AdolescentUnited States
-
Boston University Charles River CampusRecruiting
-
University of Auckland, New ZealandTe Hiringa Hauora/Health Promotion AgencyCompletedDrinking, Alcohol | Consumption, AlcoholNew Zealand
-
University of ArkansasRecruitingDrinking Behavior | Drinking Excessive | DrinkingUnited States
-
Butler HospitalNational Institute of General Medical Sciences (NIGMS)CompletedDrinking, AlcoholUnited States
-
Real Prevention, LLCCompletedUnderage Drinking | Alcohol Use, UnderageUnited States
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Active, not recruiting
-
University of North Texas Health Science CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Universidad de GranadaCompletedExercise | Drinking, AlcoholSpain
-
Lehigh UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brown UniversityCompletedCollege DrinkingUnited States
Clinical Trials on Standard treatment (ST) arm
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Abbott Medical DevicesCompletedAtrial Fibrillation | BradycardiaGermany
-
VA Office of Research and DevelopmentRecruitingSuicide | Interpersonal RelationsUnited States
-
Brown UniversityCompleted
-
Institut Claudius RegaudInstitute of Cancer Research, United Kingdom; Hellenic Cooperative Oncology... and other collaboratorsRecruitingAdenocarcinoma | Cervical Carcinoma | Adenosquamous CarcinomaFrance, Italy, Spain
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloCompletedCocaine Related DisordersBrazil
-
MD Stem CellsRecruitingGlaucoma | Age-Related Macular Degeneration | Macular Degeneration | Retinitis Pigmentosa | Leber Hereditary Optic Neuropathy | Optic Atrophy | Blindness | Optic Neuropathy | Vision, Low | Retinal Disease | Stargardt Disease | Maculopathy | Retinopathy | Optic Nerve Disease | Nonarteritic Ischemic Optic Neuropathy | Vision... and other conditionsUnited States, United Arab Emirates
-
University of WashingtonNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedFibromyalgiaUnited States
-
Association Francaise pour la Recherche ThermaleUniversité Joseph Fourier; Université Victor Segalen Bordeaux 2; HAT Consultant; AXONAL S.A...Completed
-
Centre Leon BerardRecruitingOsteosarcoma | Bone SarcomaFrance